Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Proteosome-Adjuvanted Trivalent Influenza Vaccine Challenge Study
NCT02522754Phase 2Completed
- Sponsor
- hVIVO
- Start
- Jan 2002
- Primary completion
- Jan 2004
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 2 trial of proteosome-adjuvanted trivalent inactivated influenza vaccine in influenza, sponsored by hVIVO. Started Jan 2002; status: completed.
02
Drugs
proteosome-adjuvanted trivalent inactivated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02522754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02522754.